Cancer prevention research 2006; 11(4): 284-290
Published online December 30, 2006
© Korean Society of Cancer Prevention
Joo-Won Jeong
The stability and activity of HIF-1α are regulated by various post-translational modifications, hydroxylation,
acetylation, and phosphorylation. Therefore, HIF-1α interacts with several protein factors
including PHD, pVHL, ARD1, and p300/CBP. Under normoxia, the HIF-1α subunit is rapidly degraded
via the von Hippel-Lindau tumor suppressor gene product (pVHL)-mediated ubiquitin-proteasome
pathway. Mouse ARD1 has been reported to negatively regulate the hypoxia-inducible factor 1α (HIF-1
α) protein by acetylating a lysine residue and enhancing HIF-1α ubiquitination and degradation. Herein,
it is demonstrated that ARD1 cannot affect the hydroxylation of HIF-1α, which is the major regulatory
modification for the stability. Moreover, the ARD1 expression level is downregulated by hypoxic
exposure.
Keywords: ARD1, HIF-1α, Hypoxia
Myung-Ho Bae, Moon-Kyoung Bae, Joo-Won Jeong, Se-Hee Kim, Chul-Ho Jeong, Soo-Kyung Bae and Kyu-Won Kim
Journal of Korean Association of Cancer prevention 2002; 7(2): 94-100Myung-Ho Bae, Hyun Seok Song, Soo-Kyung Bae, Seok-Ki Lee, Sae-Won Lee, Chul Woo Kim and Kyu-Won Kim
Journal of Korean Association of Cancer prevention 2002; 7(1): 27-33Seon-Ye Kim, Ja-Eun Kim, Chan Park and Joo-Won Jeong
Cancer prevention research 2008; 13(4): 252-255